Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 USD | -1.55% |
|
+6.74% | -87.09% |
06-24 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.09% | 131M | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-10.41% | 33.3B | |
+75.79% | 27.92B | |
-14.61% | 15.85B | |
-3.46% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Amylyx Pharmaceuticals Says European Medicines Agency Panel Reaffirmed Negative Opinion on Amyotrophic Lateral Sclerosis Drug